Evaluation of the humoral immune responses of brucellosis vaccine (Rev.1) in sheep: A study from Iran

The live strain of Brucella melitensis Rev1 is recognised as the available vaccine for controlling brucellosis in small ruminants. This study aimed to assess the humoral immune responses in sheep when administered the native Rev.1 vaccine. All animals were inoculated with the Rev.1 vaccine, and bloo...

Full description

Saved in:
Bibliographic Details
Main Authors: J. Gharekhani, E. Barati, M. Dadar
Format: Article
Language:English
Published: Faculty of Veterinary Medicine, Trakia University, Stara Zagora, Bulgaria 2025-03-01
Series:Bulgarian Journal of Veterinary Medicine
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832581898930487296
author J. Gharekhani
E. Barati
M. Dadar
author_facet J. Gharekhani
E. Barati
M. Dadar
author_sort J. Gharekhani
collection DOAJ
description The live strain of Brucella melitensis Rev1 is recognised as the available vaccine for controlling brucellosis in small ruminants. This study aimed to assess the humoral immune responses in sheep when administered the native Rev.1 vaccine. All animals were inoculated with the Rev.1 vaccine, and blood samples were collected on days 0, 14, 28, 44, 55, and 69 post-vaccination. These samples were tested using the modified Rose Bengal plate test (mRBPT), Wright test, 2-mercaptoethanol (2-ME) test, and enzyme-linked immunosorbent assay (ELISA) techniques. After six rounds of sampling, all animals tested negative in the mRBPT evaluation, and the control group exhibited low levels of anti-bodies to brucellosis when using ELISA. In the test group, most cases of positive mRBPT results were observed on days 14 and 28 of sampling. The Wright, 2-ME, and ELISA tests revealed that the highest antibody levels were detected 14 days after vaccination. In contrast to the Wright and 2-ME findings, the level of antibodies continued to rise until the 44th day after vaccination when using ELISA. The results demonstrated the stimulation of humoral immune responses in the target animals through the native vaccine, which could be employed to immunise livestock in endemic areas like Iran. The ELISA test proved to be more effective than conventional tests in revealing the serological response induced by Rev.1 vaccination, although ELISA may not reliably distinguish between anti-bodies generated by the vaccine and those resulting from the disease.
format Article
id doaj-art-657ff00f05ef468cb6daf3eb1d2f76b6
institution Kabale University
issn 1311-1477
1313-3543
language English
publishDate 2025-03-01
publisher Faculty of Veterinary Medicine, Trakia University, Stara Zagora, Bulgaria
record_format Article
series Bulgarian Journal of Veterinary Medicine
spelling doaj-art-657ff00f05ef468cb6daf3eb1d2f76b62025-01-30T08:33:11ZengFaculty of Veterinary Medicine, Trakia University, Stara Zagora, BulgariaBulgarian Journal of Veterinary Medicine1311-14771313-35432025-03-0128113314410.15547/bjvm.2023-0117Evaluation of the humoral immune responses of brucellosis vaccine (Rev.1) in sheep: A study from IranJ. Gharekhani0E. Barati 1M. Dadar2Central Veterinary Laboratory, Iranian Veterinary Organization, Hamedan, IranCentral Veterinary Laboratory, Iranian Veterinary Organization, Hamedan, IranRazi Vaccine and Serum Research Institute (RVSRI), Agricultural Research, Education and Extension Organization (AREEO), Karaj, IranThe live strain of Brucella melitensis Rev1 is recognised as the available vaccine for controlling brucellosis in small ruminants. This study aimed to assess the humoral immune responses in sheep when administered the native Rev.1 vaccine. All animals were inoculated with the Rev.1 vaccine, and blood samples were collected on days 0, 14, 28, 44, 55, and 69 post-vaccination. These samples were tested using the modified Rose Bengal plate test (mRBPT), Wright test, 2-mercaptoethanol (2-ME) test, and enzyme-linked immunosorbent assay (ELISA) techniques. After six rounds of sampling, all animals tested negative in the mRBPT evaluation, and the control group exhibited low levels of anti-bodies to brucellosis when using ELISA. In the test group, most cases of positive mRBPT results were observed on days 14 and 28 of sampling. The Wright, 2-ME, and ELISA tests revealed that the highest antibody levels were detected 14 days after vaccination. In contrast to the Wright and 2-ME findings, the level of antibodies continued to rise until the 44th day after vaccination when using ELISA. The results demonstrated the stimulation of humoral immune responses in the target animals through the native vaccine, which could be employed to immunise livestock in endemic areas like Iran. The ELISA test proved to be more effective than conventional tests in revealing the serological response induced by Rev.1 vaccination, although ELISA may not reliably distinguish between anti-bodies generated by the vaccine and those resulting from the disease.brucellosiselisarev.1 vaccine2- mercaptoethanol testwright test
spellingShingle J. Gharekhani
E. Barati
M. Dadar
Evaluation of the humoral immune responses of brucellosis vaccine (Rev.1) in sheep: A study from Iran
Bulgarian Journal of Veterinary Medicine
brucellosis
elisa
rev.1 vaccine
2- mercaptoethanol test
wright test
title Evaluation of the humoral immune responses of brucellosis vaccine (Rev.1) in sheep: A study from Iran
title_full Evaluation of the humoral immune responses of brucellosis vaccine (Rev.1) in sheep: A study from Iran
title_fullStr Evaluation of the humoral immune responses of brucellosis vaccine (Rev.1) in sheep: A study from Iran
title_full_unstemmed Evaluation of the humoral immune responses of brucellosis vaccine (Rev.1) in sheep: A study from Iran
title_short Evaluation of the humoral immune responses of brucellosis vaccine (Rev.1) in sheep: A study from Iran
title_sort evaluation of the humoral immune responses of brucellosis vaccine rev 1 in sheep a study from iran
topic brucellosis
elisa
rev.1 vaccine
2- mercaptoethanol test
wright test
work_keys_str_mv AT jgharekhani evaluationofthehumoralimmuneresponsesofbrucellosisvaccinerev1insheepastudyfromiran
AT ebarati evaluationofthehumoralimmuneresponsesofbrucellosisvaccinerev1insheepastudyfromiran
AT mdadar evaluationofthehumoralimmuneresponsesofbrucellosisvaccinerev1insheepastudyfromiran